Necrostatin 1 (Nec1) is widely used in disease models to examine the contribution of receptor-interacting protein kinase 1 in cell death. The biological actions of Nec1 are blocking necrotic cell death. The purpose of this study was to investigate whether adding Nec1 into in vitro maturation (IVM) media, followed by vitrification procedures, could enhance the survival and developmental competency of oocytes. Germinal vesicle oocytes were matured in IVM medium containing 2 different doses of Nec1 (0.5 and 1 mmol/L). After IVM, the oocytes were vitrified using a 2-step exposure to equilibrium and vitrification solutions. After warming, the rates of survival, fertilization, embryonic development up to blastocyst in vitro, morphology of spindle and chromosome, membrane integrity, mitochondria integrity, and several gene expressions were evaluated. The survival and developmental competency of oocytes were higher in the 1 mmol/L Nec1-treated group than control. The proportion with intact spindles/chromosomes and stable membranes was similar in all the groups. The mitochondrial integrity of all Nec1-treated groups showed a higher score with strong staining. The 1 mmol/L Nec1 showed significantly increased expressions of Mad2, Gdf9, and Bcl2. The Cirp level had a tendency to be downregulated in the 0.5 mmol/L Nec1 but upregulated in the 1 mmol/L Nec1, compared with the control. The Mtgenome expressions were significantly decreased in both Nec1 groups. The supplementation of 1 mmol/L Nec1 into the IVM medium could be beneficial for the survival and development of immature oocytes after vitrification.
Introduction
Oocyte vitrification has been a significant strategy to preserve fertility for teenage girls and young women without male partners. A variety of improved cryoprotocols and tools have conspicuously enhanced oocytes survival and contributed to increased pregnancy and live birth rates. [1] [2] [3] [4] [5] [6] [7] There are a few effective clinical options for preserving female fertility. Traditionally, embryo cryopreservation was the common method, followed by in vitro fertilization (IVF). However, many young reproductive-age female patients with cancer do not benefit in terms of preserving their fertility using embryo cryopreservation. In addition, ovarian stimulation with gonadotropins in the IVF cycle is not suitable in some patients with cancer who are having breast cancer or who require immediate chemotherapy. In most fertility centers, retrieved immature oocytes are usually allowed to mature in vitro and are then vitrified at metaphase II (MII). 8, 9 Although the survival rate of immature oocytes seems improved compared with MII oocytes, the poor maturation and fertilization of oocytes and the poor embryonic development up to the blastocyst stage are the major problems related to immature oocyte freezing. 10, 11 In addition, according to Cao et al, oocytes vitrified at the germinal vesicle (GV) stage and at the MII stage exhibit similar survival rates, and oocytes vitrified at the GV stage showed substantially less maturation rates than oocytes vitrified at the MII stage. 12 Because of these problems, vitrification at the MII stage seems to be a more proper method according to previous researches.
In cell culture systems, safe and essential factors such as consistent temperature, growth factors, and nutrients are important to success culture. Normally, most researchers have tried to find the best culture system, which is similar in conditions compared to in vivo for their experiments. However, most culture systems have been always exposed from harmful circumstances because it could not be the same as in vivo. Hence, more effective culture methods need to be developed for avoiding harmful effect such as apoptosis or necrosis on in vitro cultured cell.
Necrostatin 1 (Nec1) is widely used in disease models to examine the contribution of receptor-interacting protein kinase 1 (RIP1) in cell death and inflammation. There are 2 principal types of cell death according to morphological appearance, apoptosis and necrosis. 13 ''Necroptosis'' is a recently coined term that refers to 1 specific form of programmed necrosis that is induced by stimulating death receptors with agonists such as tumor necrosis factor a (TNF-a), Fas ligand, and TNF-related apoptosis-inducing ligand. Necroptosis has its own unique signaling pathway, which requires the involvement of RIP1 and RIP3. Receptor-interacting protein kinase 1, best known for its function in nuclear factor kB activation, 14, 15 also plays a critical role in necroptosis. Receptorinteracting protein kinase 3, a RIP1 family member, has recently been implicated in necroptosis. [16] [17] [18] According to 1 recent research, Nec1 suppressed the apoptosis and cleaved caspase 3 protein levels in a mouse intracerebral hemorrhage model. Also, Nec1 treatment improved the expression of Bcl2 protein in mouse model. 19 Although the function of Nec1 is not fully understood, Nec1 might regulate the apoptosis-related gene and protein expression in mouse cells. In addition, it is known to be a potent inhibitor of RIP1 kinase activity and is able to inhibit the interaction between RIP1 and RIP3 upon the activation of necroptosis.
In this study, we added Nec1 to in vitro maturation (IVM) medium used for the maturation of immature mouse oocytes for the first time. Our aim was to determine whether Nec1 supplementation during IVM improves the rates of survival, fertilization, and developmental competence up to blastocyst formation of oocytes matured in vitro and embryo production after cryopreservation. To evaluate the effect of Nec1, we used Nec1-treated oocytes and nontreated control oocytes that survived after vitrification for examining spindle morphology, testing membrane integrity, staining for mitochondrial membrane potential, and testing for the expression of genes related to oocyte development and spindle formation.
Methods

Animals
B6D2F1 female mice (5-6-week-old) were used in all experiments. The Institutional Animal Care and Use Committee (IACUC) of Seoul National University Bundang Hospital approved this study. Animals were cared for according to the guidelines of IACUC.
Retrieval of Immature Oocytes
We injected mice intraperitoneally with 7.5 IU pregnant mare's serum gonadotropins (Sigma-Aldrich, St Louis). After 48 hours, the stimulated mice were killed by cervical dislocation, and ovaries were dissected and placed in 1 mL of washing (collection) medium. The washing medium used was mouse tubal fluid (MTF) 20 supplemented with additional components (modified MTF [mMTF]). The mMTF contained MTF plus 0.4% (w/v) bovine serum albumin (BSA; Sigma), 1% (v/v) nonessential amino acids (11140-050; Gibco, Grand Island), 1% (v/v) essential amino acid (R7131; Sigma), 0.5% (v/v) Lglutamine (25030-081; Gibco), and 0.25% (v/v) multivitamins (11120-052; Gibco). By puncturing the antral follicles, we isolated intact cumulus-oocyte complexes (COCs).
In Vitro Maturation
Collected good-quality COCs were incubated in IVM medium for 18 hours at 37 C in a humidified chamber with 5% CO 2 . Basal medium was commercial TCM-199 (Invitrogen, Carlsbad), which we supplemented with 20% fetal bovin serum (FBS; Invitrogen), recombinant follicle-stimulating hormone and human chorionic gonadotropins (75 mIU/mL and 0.5 IU/ mL; Serono, Geneva, Switzerland), and recombinant epidermal growth factor (10 ng/mL; Sigma). For experimental groups, 0.5 or 1 mmol/L of Nec1 (N9037; Sigma) was added to the IVM medium. We used a group culture system. Ten oocytes were cultured in a drop under mineral oil. After the maturation period, we denuded all COCs by applying 85 IU/mL hyaluronidase to confirm maturation, which was evaluated based on the extrusion of the first polar body. This observation was performed under an inverted microscope (200Â magnification). The nonvitrified control group oocytes were matured, fertilized, and developed up to blastocyst stage.
Vitrification and Warming of Oocyte
We performed oocyte vitrification in equilibrium solution (ES) and vitrification solution (VS). Base solution (BS) consisted of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid-buffered TCM-199 medium supplemented with 20% (v/v) FBS (Invitrogen). Equilibrium solution contained 7.5% (v/v) ethylene glycol (EG) and 7.5% (v/v) 1,2-propanediol (PROH) in BS solution. Vitrification solution contained 15% (v/v) EG, 15% (v/v) PROH, and 0.5 mol/L sucrose in BS solution. The oocytes were submerged in ES for 5 minutes and then transferred to VS for 45 to 60 seconds at room temperature (RT). Approximately 5 to 6 oocytes were placed on a CryoTop (Kitazato, Shizuoka, Japan) and then plunged immediately into liquid nitrogen for storage.
For warming oocytes, we prepared a warming solution (WS), which was BS containing sucrose at 1.0 mol/L (WS1), 0.5 mol/L (WS2), and 0.25 mol/L (WS3). The CryoTops containing the oocytes were immersed directly in WS1 at 37 C for 1 minute. The processed oocytes were transferred to WS2 and WS3 for 3 minutes each and then washed twice with BS (washing solution). Warmed oocytes were transferred to fertilization medium at 37 C and maintained with 5% CO 2 in humidified air. To assess the survival rate of oocytes, they were cultured for 1 hour more. We counted the oocytes that survived, which were identified morphologically based on the appearance of membrane integrity and discoloration of the ooplasm. The surviving oocytes were used for subsequent experiments.
In Vitro Fertilization
The oocytes that survived after warming were fertilized using epididymal sperm. We used epididymal spermatozoa obtained from the cauda epididymis of 8-to 10-week-old male B6D2F1 mice. For capacitation, the collected spermatozoa were preincubated for 1.5 hours in fertilization medium (mMTF supplemented with 0.8% BSA). Sperm at a final dilution of 2 Â 10 6 /mL were used to inseminate oocytes, which were incubated at 37 C in humidified air with 5% CO 2 . After 6 hours, inseminated oocytes were washed twice by moderate pipetting and then placed in embryo maintenance medium (Global medium supplemented with 10% human serum albumin; Life Global, North Carolina). To assess fertilization, development of the 2-cell stage was measured 1 day after insemination. The cleaved embryos were transferred to new embryo maintenance medium, and their development up to blastocyst formation was evaluated on day 5 after insemination.
Spindle and Chromosome Staining
We incubated the oocytes that survived after vitrification for 1 hour in humidified air with 5% CO 2 for spindle reassembly and chromosomal distribution after warming. The cultured oocytes were fixed with 4% paraformaldehyde for 10 minutes and were then washed in PBS; the washed oocytes were transferred to 0.25% Triton X-100 in PBS for 10 minutes at RT and then washed twice before blocking. For blocking, the oocytes were submerged in 2% BSA in PBS for 1 hour at RT. After rinsing in PBS, the oocytes were incubated overnight at 4 C with b-tubulin polyclonal antibody (1:100 dilution; Cell Signaling, United Kingdom). The oocytes were then washed twice in PBS and stained in the dark (1 hour, 37 C) with fluorescein isothiocynate (FITC)-conjugated antirabbit immunoglobulin G (Abcam, United Kingdom). The stained oocytes were rinsed twice in PBS and then mounted on glass slides with coverslips; we used Vectorshield mounting medium (Vector Laboratories, Burlingame, California) containing 0.5 mg of 4 0 ,6-diamidino-2phenylindole (DAPI). To assess spindle and chromosomal localization, we used a fluorescence microscope (Leica DMIL, Germany) equipped with a Hamamatsu digital camera imaging system and observed the samples under 400Â magnification. The spindle and chromosomes were considered to be intact when oocytes displayed barrel-shaped microtubules and centrally aligned chromosomes between the 2 poles. Damaged or missing meiotic spindles and chromosome misalignments were considered abnormal ( Figure 1 ).
Membrane Integrity Evaluation
Warmed oocytes that survived were incubated in PBS for membrane staining. To these oocytes, we added 5 mg/mL BSA, 1 mg/mL fluorescein diacetate (FDA; Sigma), and 50 mg/mL propidium iodide (PI; Sigma) in PBS for 10 minutes. 21 After being exposed to FDA, most live cells that are intact and normal accumulate fluorescein intracellularly. Thus, the stained oocytes appeared green under fluorescence microscopy when they were intact. Propidium iodide has 2 characteristics, the dye potently stains nuclei and PI can be used to detect entire nonintact cells or parts of them. We regarded oocytes stained by both FDA and PI to be alive but to have damaged parts. 22 
Oocytes Mitochondrial Staining by JC-1
All oocytes in controls and Nec1 groups were stained by the DCm-specific probe JC-1 (Invitrogen). JC-1 was diluted to final concentration of 5 mg/mL in mMTF. All oocytes were stained in a humidified incubator containing 5% CO 2 at 37 C for 30 minutes. The JC-1 reaction was conducted in darkness. The stained oocytes were examined by epifluorescence microscopy in the FITC and rhodamine-B isothiocyanate (RITC) channels using narrow band path filter sets anddivided into 3 grades which consisted of strong, moderate, and weak staining groups, respectively. Because there were no standard references, we divided the grades into 3 criteria based on our own discretion. In a recent study, we divided 3 evaluation standards according to the characteristics of JC-1 (strong, moderate, and weak staining). In the strong red per green staining, the red fluorescence located around the periphery of oocytes represents a higher mitochondrial membrane potential, whereas the green fluorescence dispersed within the oocytes represents a lower mitochondrial membrane potential ( Figure 2 ). The moderate red per green staining is similar to strong grade, but the red fluorescence is weaker than in the strong staining. The weak red per green staining has far weaker red fluorescence than moderate group. In weak grade, the red fluorescence was almost not detected in the oocyte periphery site or cytoplasm. These staining grades are presented in Figure 2 . We counted each of oocyte of red per green staining according to 3 grades. The determination method using JC-1 on oocyte staining has not yet been standardized. So, we had to make our score criterion. To add accuracy, 5 researchers evaluated each oocyte and calculated average scores.
Quantitative Real-Time Polymerase Chain Reaction Analysis
We used the Dynabeads messenger RNA (mRNA) DIRECT micro kit (Dynal Asa, Oslo, Norway) to extract mRNA from vitrified-warmed oocytes from experimental and control groups. Each of mRNA sample used 5 oocytes. All extraction steps were completed according to the manufacturer's instructions. After extracting and purifying RNA, we synthesized complementary DNA (cDNA) from the mRNA using 50 ng/ mL random hexamer primers designed following the Super-Script protocol. When calculating the amount of mRNA in groups, we used iCycler (Bio-Rad, Hercules, California) to assess our quantitative real-time polymerase chain reaction (PCR) results. We used the iCycler iQ real-time detection system software to evaluate the results. The reaction mixture contained 20 pmol of primers (reverse and forward), cDNA, and SYBR Green Supermix2 (50 U/mL iTaq DNA polymerase, 6 mmol/L MgCl 2 , 100 mmol/L KCl, SYBR Green I, 40 mmol/ L Tris-HCl, pH 8.4, 20 nmol/L fluorescein, 0.4 mmol/L of each deoxynucleotide triphosphate, and stabilizers). Templates were amplified for 45 cycles as follows: denaturation at 95 C for 10 seconds, annealing at 55 C for 15 seconds, and extension at 72 C for 20 seconds. Until the PCR amplifications were completed, we continuously monitored the fluorescence while slowly heating the samples from 55 C to 95 C at 0.5 C intervals. To identify any nonspecific amplification products, we used the melting curves obtained. We performed quantitation of gene amplification to determine the cycle threshold (C T ) that was based on fluorescence detected within the geometric region of the semilog amplification plot. All mRNA expressions were normalized to that of mouse glyceraldehyde 3-phosphate dehydrogenase mRNA. We used the comparative C T method to evaluate relative quantitation of target gene expression. The experiments were repeated at least 6 times using different sets of oocytes. All sequence information in these experiments are presented in Table 1 .
Differential Staining of Blastocysts
Blastocysts were fixed in 4% paraformaldehyde (Sigma) for 20 minutes at RT and stored in PBS containing 0.5% BSA (Sigma) at 4 C until the staining was performed. The blastocysts were incubated overnight in 0.5% Triton X-100 (Sigma) in PBS at 4 C. Subsequently, the blastocysts were washed 3 times for 2 minutes in PBS-BSA. On the second day, blastocysts were transferred to the blocking solution. Blocking occurred overnight in 10% goat serum (Invitrogen) in PBS at 4 C. The test blastocysts were washed and incubated in the ready-to-use primary OCT3/4 antibody (Invitrogen) for 1 day at 4 C. After another wash step (2 times 15 minutes), blastocysts were labeled with secondary Alexa 594-conjugated antibody diluted 1:100 (Invitrogen) for 1 day at 4 C. After washing in PBS, the samples were mounted onto a slide under a coverslip in Vectorshield mounting medium (Vector Laboratories) containing 0.5 mg/mL of DAPI. 
Caspase Staining of Blastocysts
We stained the apoptotic parts of blastocysts using the CaspaTag Pan Caspase in situ assay kit according to the manufacturer's instructions (Millipore, New Bedford). To set up positive controls, blastocysts were immersed in 0.1% (v/v) H 2 O 2 in PBS for 1 minute. Negative controls were not exposed to the dye used for staining; instead, the blastocysts were incubated in PBS only. Stained blastocysts were mounted on slides and examined using fluorescence microscopy. Caspase-positive cells were identified by their green fluorescence, and nuclei were identified by DAPI staining. Caspase positivity was measured as the ratio of caspase-positive blastomeres to the total number of nuclei ( Figure 3 ).
Statistical Analyses
These experiments of developmental competence and spindle staining were repeated at least 4 times with different pools of samples. The membrane integrity and mitochondrial membrane potential test were repeated at least 3 times. Means and standard deviations were compared using the Student t-test. The proportions were compared using the chi-square tests. Relative mRNA abundance differences in control group and Nec1-treated groups were analyzed using 1-way analysis of variance (ANOVA) test. Significant results in the ANOVA were further analyzed by the Tukey test. Differences were considered statistically significant when P < .05. All data were analyzed using the SPSS for Windows (Version 18.0; SPSS, Inc, Chicago, Illinois). 
Results
Effect of Nec1 on the Developmental Competence of Oocytes
Oocyte maturation rates were significantly higher in the Nec1treated groups (91.8%, 0.5 mmol/L Nec1; 92.2%, 1 mmol/L Nec1) than in the untreated group (85.1%) and nonvitrified control group. These results suggest that supplementing the IVM medium with Nec1 alleviates the detrimental effects of environmental factors during the IVM process. This was especially true for Nec1 used at 1 mmol/L. After IVM, successfully matured oocytes were vitrified and warmed. In this study, we determined that oocyte survival rate in the group treated with 1 mmol/L Nec1 was significantly higher than that in the untreated group (95.8% vs 89.6%). After warming, the oocytes that survived and nonvitrified control group were fertilized with motile sperm in IVF medium for 6 hours. After washing off the sperm, the oocytes were transferred to IVF medium and incubated. After incubation for 1 day, the cleavage rates were determined to be significantly higher in the group treated with 0.5 mmol/L Nec1 than in the control (without Nec1) group (77.0% vs 66.7%). Treatment with 1 mmol/L Nec1 resulted in a higher cleavage rate than control (without Nec1), but it was not significantly different from the 0.5 mmol/L Nec1 group (75.2% vs 77.0%; 1 mmol/L Nec1 vs 0.5 mmol/L Nec1). Cleaved embryos were transferred to cleavage media and maintained for 4 days until they reached the blastocyst stage. Blastocyst formation rates (blastocyst per surviving oocyte) were significantly higher in the 0.5 and 1 mmol/L Nec1-treated groups than in the control (without Nec1) group (22.5% and 21.9% vs 11.6%). Total blastomere and trophectoderm and inner cell mass cell counts were similar across the control groups and Nec1-treated groups. Caspase positivity was slightly decreased in the Nec1-treated groups (Figure 3 ), but this was not statistically different ( Table 2 ).
Effect of Nec1 on the Meiotic Spindle and Chromosome Morphology of Vitrified-Warmed Oocytes
We observed similar proportions of oocytes with normal spindle and chromosome morphologies in the control (without Nec1) and Nec1-treated groups (78.8% vs 79.7% vs 69.9%; control vs 0.5 mmol/L Nec1 vs 1 mmol/L Nec1). However, experimental groups (Nec1-treated groups) did not reach the results of nonvitrified control group (normal spindle: 96.4%). These results reflected that the cleavage rates after fertilization were not corroborated by adding Nec1 during IVM. Hence, our results suggest that adding Nec1 during IVM does not enhance spindle protection and chromosome conservation after vitrification ( Table 3 ).
Effect of Nec1 on Membrane Integrity
We treated oocytes with FDA and PI to determine the ''live and intact'' status and ''live with some of damage'' status of oocytes. Live and intact oocytes exhibited only green fluorescence, whereas oocytes that were alive but had damaged parts presented both green and red fluorescence. 22 The results of membrane integrity tests showed that the percentages of live (intact) oocytes in the control (without Nec1) and experimental groups were similar (86.1%, 86.3%, and 85.7%). However, experimental groups (Nec1-treated groups) did not reach the results of nonvitrified control group (intact live oocytes: 97.8%; Table 4 ).
Effect of Nec1 on Mitochondrial Membrane Potential
We evaluated the mitochondrial membrane potential (DCm) in mouse oocytes using JC-1 (5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0tetraethylbenzimidazolyl-carbocyanine iodide); for these experiments, we used warmed oocytes that had survived. Previously, DCm was reported to be a sensitive index to measure oocyte damage, which is because DCm is easily affected by the environmental conditions. 23 The specific characteristics of JC-1 are the following. When the mitochondrial membrane potential is a low, JC-1 exists as a monomer, and green fluorescence can be detected in the FITC channel. By contrast, when the potential increases, JC-1 monomers assemble into arrays termed J-aggregates, which exhibit red fluorescence; thus, at high a mitochondrial membrane potential (DCm), red fluorescence is detected in the RITC channel. 24 JC-1 is an especially suitable probe for measuring DCm because the red fluorescence and green fluorescence of JC-1 rely only on DCm and are unaffected by other factors such as the size of oocytes and the number mitochondria. In the test for mitochondrial integrity, significantly higher proportions of oocytes with strong red fluorescence were observed in the 0.5 and 1 mmol/L Nec1 groups than in the control group (without Nec1). In the 0.5 mmol/L Nec1-treated group, the weak red fluorescence signals were significantly lower than the control (without Nec1) and 1 mmol/L Nec1-treated groups. However, experimental groups (Nec1-treated groups) did not reach the results of nonvitrified control group in strong signal proportion ( Table 5 ).
Expression of Candidate Target Genes in Mouse Oocytes After Vitrification
Expression levels of Mad2, Gdf9, and Bcl2 were significantly higher in the 1 mmol/L Nec1-treated group than in the control (without Nec1) or 0.5 mmol/L Nec1-treated groups. By contrast, the expression of the Mtgenome was significantly lower in both Nec1 groups. All candidate target genes were analyzed using real-time PCR (Figure 4 ).
Discussion
When IVF centers retrieve immature oocytes, they usually prefer to perform the IVM first and then the vitrification at MII. 8, 9 Because most researchers think that GV-stage oocyte vitrification cause a loss of maturation capability, in the present study, we showed that pretreatment with Nec1 during IVM might be beneficial to improve the developmental competence of oocytes. Because of Nec1 treatments, our oocyte vitrification protocol could be more effective in vitrified-warm oocyte survival rates. For deciding the concentration of Nec1 to oocyte, we divided 4 groups (0.1, 0.5, 1, and 5 mmol/L, respectively). In our results, 100 nmol/L could not improve the maturation and survival rates compared to 0.5 and 1 mmol/L. In addition, 5 mmol/L group showed the lower survival rate compared to 1 mmol/L groups. According to these results, we performed the further study by nontreated control, 0.5 mmol/L Nec1, and 1 mmol/L groups, respectively. Once we determined the concentration ranges of Nec1, we needed to test to decide the effective periods when we exposed the oocytes to Nec1. First of all, we added Nec1 to vitrification medium only following IVM. In this experiment, we did not obtain the positive effects on oocyte survival rates after warming (87.3%, 0.5 mmol/L Nec1; 86.8%, 1 mmol/L Nec1). Second, we supplemented Nec1 to IVM and vitrification medium. At this time, enhanced maturation (90.7%, 0.5 mmol/L Nec1; 93.3%, 1 mmol/L Nec1) and survival rates (90.8%, 0.5 mmol/ L Nec1; 91.3%, 1 mmol/L Nec1) were observed compared to nontreated control group. Finally, we added Nec1 to IVM medium only. The last experiment denoted that exposing Nec1 to oocytes during IVM presented the highest survival rate (94.7%, 0.5 mmol/L Nec1; 95.8%, 1 mmol/L Nec1) and developmental competence. Interestingly, the first experiment could not show enhanced survival and fertilization rates. It might be explained that enough exposing time of Nec1 to oocyte was essential to improve the results. In addition, second test showed elevated survival and fertilization rates compared with the first test. However, it did not reach the results of survival and developmental competence of the third test. It could be suggested that optimal exposure of oocyte to Nec1 might be important. Hence, we adapted Nec1 to IVM medium only for further studies.
In the present study, significantly higher proportions of oocytes with maturation and survival rates were observed in the Nec1-treated group. This result suggests that Nec1 supplementation could help to preserve the oocyte from a variety of harsh conditions during the oocyte maturation periods and subsequent vitrification. This is the first study on the effect of Nec1 pretreatment on oocyte vitrification outcomes, and improved oocytes survival and fertilization and subsequent embryonic development were observed in the Nec1-treated groups.
In our previous reports, vitrification and warming procedures affected the spindle-chromosome integrity and membrane stability. 22, 25 Especially, antifreeze protein supplementation of the vitrification medium brought protective effects on vitrifiedwarmed oocytes. 25 However, with regard to the results of spindle and membrane integrity in this report, Nec1 supplementation during IVM was not effective in protecting oocytes from the vitrification procedure. All groups presented similar results of normal or abnormal percentages of spindlechromosome morphology. In addition, in the membrane integrity test, live but damaged oocytes were present in the same proportion among the groups. Hence, Nec1 supplementation might not protect the spindle and membrane in oocytes during vitrification.
Mitochondria play an important role in the metabolism of energy-containing compounds in the oocyte cytoplasm to provide adenosine triphosphate (ATP) for fertilization and preimplantation embryo development. A higher proportion of oocytes with strong periphery red fluorescence were observed in both Nec1-treated groups ( Table 5 ). From these results, it can be inferred that Nec1 supplementation was beneficial in maintaining the mitochondrial membrane potential after warming.
The expression of various genes within the oocyte can be modulated by vitrification. 26 Mad2 is a meiotic checkpoint protein that regulates anaphase onset and genome integrity in the oocyte. 27, 28 In this study, we observed significantly higher levels of Mad2 transcripts in oocytes treated with 1 mmol/L Nec1 than in untreated oocytes, suggesting that Nec1 elevates Mad2 mRNA expression. However, in the 0.5 mmol/L Nec1-treated group, the Mad2 transcript level was slightly lower than that in the control (without Nec1). Considering our spindle and chromosomal results, Nec1 pretreatment during IVM might not be related to Mad2 expressions and spindle conservation after vitrification. Growth factor 9 (Gdf9) is a kind of growth factor made by ovarian somatic cells. It could affect oocyte for growth or function. During early folliculogenesis, Gdf9 is considered as essential factor to complete ovarian growth. 29 In addition, Gdf9 had various functions such as granulose cell, theca cell, and oocyte maturation. 30 In this study, we found that significantly higher expression levels of Gdf9 in oocytes treated with 1 mmol/L Nec1 than in control (without Nec1) group. It suggested that potentially upregulated Gdf9 at 1 mmol/L Nec1 group might help a more successful maturation and have better quality on immature oocyte.
Apoptosis-related genes such as Bcl2 and Bax were examined in this study. Bcl2 is an antiapoptotic gene that has been reported to promote cell survival by suppressing apoptosis. 31 Conversely, Bax is activated under proapoptotic conditions, and Bax function accelerates cell death through apoptosis. 32 In our study, Bcl2 expression was significantly upregulated in the 1 mmol/L Nec1-treated group, but in the 0.5 mmol/L Nec1-treated group, it was similar to that in the control (without Nec1). Bax had a tendency to be downregulated in 0.5 mmol/L Nec1-treated groups and the 1 mmol/L Nec1-treated group showed similar expressions to that in the control (without Nec1) group (not significantly different). It could be assumed that 0.5 mmol/L was profitable considering normal theory. Although 1 mmol/L Nec1-treated group showed upregulated Bax expression compared with 0.5 mmol/L Nec1-treated group, developmental competency of 1 mmol/L Nec1 was better than 0.5 mmol/L Nec1. It might be presumed that more upregulated Bcl2 expression offsets the upregulated Bax. Taken together, these results suggest that Nec1 may affect Bcl2 expressions after vitrification and gives some protective effect to vitrified-warmed oocytes.
In this study, adding Nec1 to the medium did not affect the expression of Cirp and Rbm3 in oocytes. This finding might be explained by the preservation of Cirp and Rbm3 mRNA levels. Cirp and Rbm3 are genes related to cold injury. Cirp has been recently introduced into mouse somatic cells under the cold condition of 32 C in vitro, and these 2 genes might have cryoprotective effects on cells. 33, 34 Thus, we examined whether Nec1 affects these genes and found that at concentrations of 0.5 and 1 mmol/L, Nec1 did not affect their expression relative to the controls. Interestingly, both Cirp and Rbm3 expression levels were downregulated in 0.5 mmol/L Nec1-treated group compared with control (without Nec1) group and upregulated in 1 mmol/L Nec1-treated group. It might be assumed that optimal concentration of Nec1 had to be used for regulating gene expression. Further studies are needed to establish the gene expression patterns according to Nec1 concentrations.
The well-reserved mitochondria after cryopreservation is an important factor for further development. 35 In our present studies, mitochondria-related gene such as Mtgenome was investigated. The expression of Mtgenome was significantly decreased in both Nec1-treated groups. Surprisingly, the DCm staining results noted that both Nec1-treated groups had a relatively higher DCm value. It is possible to explain this, as a previous study by Steuerwald et al reported that the mitochondrial DNA copy number was increased in the oocytes of older women. 36 Such increase in mitochondrial biogenesis was attributed to a compensatory phenomenon to guarantee sufficient ATP production in the event of either an increased demand or a respiratory chain dysfunction. Considering these results, the decreased Mtgenome expression levels in both Nec1-treated groups, compared with the control (without Nec1) group, might be profitable consequences, although we did not perform the Western blotting tests. Because properly protected mitochondria in oocyte from vitrification and warming processes were already sufficient in the cytoplasm of Nec1-treated oocytes, it might be possible that gene such as Mtgenome might be potentially downregulated at gene levels.
In conclusion, we have demonstrated positive effects of Nec1 on the IVM and vitrified mouse oocytes for the first time. Supplementing IVM medium with Nec1 increased the maturation, survival, IVF, and embryonic developmental competence of immature oocytes. Thus, Nec1 might exhibit a cryoprotective effect under harsh in vitro conditions. The Nec1 was also observed to stabilize mitochondrial function in oocytes and affect the expression of various genes. Therefore, the positive effects of Nec1 on the survival and developmental competence of oocytes might be explained by enhanced mitochondrial integrity. Furthermore, Nec1-dependent modulation of the expression of Mad2, Gdf9, Mtgenome, and Bcl2 may increase the fertilization and developmental competence of oocytes.
